WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'7701 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 9'9041 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 3'810  3'818  3'824  3'828  3'832  3'793  4'527  4'145 
Births 34  34  35  35  35  39  64  77 
Surviving infants 33  34  34  35  35  38  63  75 
Pop. less than 5 years 172  177  184  189  188  218  357  361 
Pop. less than 15 years 514  521  533  548  560  728  1'098  1'177 
Female 15-49 years 899  909  918  927  936  987  1'180  1'128 

Number of reported cases

(Click for retrospective incidence data for Bosnia and Herzegovina)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  1'677  3'000  22  10  43  512 
Mumps
ChartChart
  56  7'881  8'209  3'577 
Pertussis
ChartChart
  12  19  30  43  287 
Polio*
ChartChart
 
Rubella
ChartChart
  17  31  144 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bosnia and Herzegovina)
Vaccine year result method % card seen                                                
BCG 2010  99  MICS   91  95  98  96  94  93 
DTP1 2010  98  MICS   91  89  92  95  94  90 
DTP3 2010  92  MICS   91  82  86  92  88  85 
DTP4          72  74 
IPV1          87  93 
HepB_BD          96  99  96  95 
HepB3          82  89  92  88  85 
Hib3          78  79  87  85 
JapEnc         
MCV1          83  89  94  89  80 
MCV2          88  92  94  88  74 
PCV1         
PCV3         
Pol3 2010  91  MICS   91  74  86  87  89  87 
Rota1         
RotaC         
Rubella1          84  89 
TT2plus          92  93  94  87 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bosnia and Herzegovina)
BCG
ChartChart
  95  98  97  96  94  93 
DTP1
ChartChart
  89  92  94  95  94  90 
DTP3
ChartChart
  82  86  89  92  88  85 
HepB3
ChartChart
  82  89  91  92  88 
HepB_BD
ChartChart
  67  74  97  96  95 
Hib3
ChartChart
  78  79  83  87  85 
IPV1
ChartChart
  56 
MCV1
ChartChart
  83  89  92  94  89  80 
MCV2
ChartChart
  88  92  93  94  88  74 
PCV3
ChartChart
 
Pol3
ChartChart
  74  86  87  87  89  87 
RCV1
ChartChart
  83  89  92  94  89  80 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5-6 years; No
DTaPHibHepB No From May 2016
DTaPIPV 2, 4, 6 months; 5 years; No
DTwP 2, 3-4, 4-6, 18 months or 5 years; Yes
DTwPHibIPV 2, 4, 5 months;
HepB_Adult risk groups
HepB_Pediatric birth; 1-2, 6 months; Yes
Hib 2, 3-4, 4, 18 months or 5 years; Yes
Influenza_Adult Yes elderly, adults with chronic illness, health care workers, Haj or travelers, and other risk groups
Influenza_Pediatric Yes children with chronic illness
MMR 12 months; 6 years; Yes
OPV 2, 3-4, 4-6, 18 months; 5-6, 14 years; No
TT 18 years; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No    No  No  No  No  Yes 
What years does the MYP cover? number             2001-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 17    10  10  18  16  10 

System performance

Total Nº districts in country number 142      18  18  16  10 
Nº districts with DTP3 coverage >=80% number 11      17  16  10 
% of districts with DTP3 coverage >=80% From 0 to 100%     94  89  56  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100%     39  33  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%       100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.